JPWO2023057935A5 - - Google Patents
Info
- Publication number
- JPWO2023057935A5 JPWO2023057935A5 JP2024520688A JP2024520688A JPWO2023057935A5 JP WO2023057935 A5 JPWO2023057935 A5 JP WO2023057935A5 JP 2024520688 A JP2024520688 A JP 2024520688A JP 2024520688 A JP2024520688 A JP 2024520688A JP WO2023057935 A5 JPWO2023057935 A5 JP WO2023057935A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- binding protein
- peptide
- optionally
- lipidated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021903192A AU2021903192A0 (en) | 2021-10-06 | Lipid nanoparticle comprising a RNA-binding protein | |
| AU2021903192 | 2021-10-06 | ||
| PCT/IB2022/059527 WO2023057935A1 (en) | 2021-10-06 | 2022-10-06 | Lipid nanoparticle comprising a nucleic acid-binding protein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024536360A JP2024536360A (ja) | 2024-10-04 |
| JP2024536360A5 JP2024536360A5 (https=) | 2025-10-01 |
| JPWO2023057935A5 true JPWO2023057935A5 (https=) | 2025-10-01 |
Family
ID=85803963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520688A Pending JP2024536360A (ja) | 2021-10-06 | 2022-10-06 | 核酸結合タンパク質を含む脂質ナノ粒子 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240398941A1 (https=) |
| EP (1) | EP4412592A4 (https=) |
| JP (1) | JP2024536360A (https=) |
| AU (1) | AU2022361756B2 (https=) |
| WO (1) | WO2023057935A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024250317A1 (en) * | 2023-04-05 | 2025-11-06 | Seqirus Inc. | Rna delivery vehicle |
| CN120617495A (zh) * | 2025-07-16 | 2025-09-12 | 深圳纳维疫苗科技有限公司 | 一种hpv重组蛋白治疗疫苗的制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6210707B1 (en) * | 1996-11-12 | 2001-04-03 | The Regents Of The University Of California | Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| JP2006506101A (ja) * | 2002-11-13 | 2006-02-23 | ルトガーズ、ザ ステイト ユニバーシティ | インフルエンザウイルス非構造タンパク質１の阻害剤を設計する方法 |
| WO2010087994A2 (en) * | 2009-01-30 | 2010-08-05 | Whitehead Institute For Biomedical Research | Methods for ligation and uses thereof |
| ES2762873T3 (es) * | 2012-03-29 | 2020-05-26 | Translate Bio Inc | Lípidos catiónicos ionizables |
| EP2875128B8 (en) * | 2012-07-19 | 2020-06-24 | Oxford Nanopore Technologies Limited | Modified helicases |
| US9809632B2 (en) * | 2013-10-23 | 2017-11-07 | University Of Washington Through Its Center For Commercialization | Universal protein tag for double stranded nucleic acid delivery |
| SG10201912038TA (en) * | 2014-04-23 | 2020-02-27 | Modernatx Inc | Nucleic acid vaccines |
-
2022
- 2022-10-06 JP JP2024520688A patent/JP2024536360A/ja active Pending
- 2022-10-06 WO PCT/IB2022/059527 patent/WO2023057935A1/en not_active Ceased
- 2022-10-06 US US18/699,125 patent/US20240398941A1/en active Pending
- 2022-10-06 AU AU2022361756A patent/AU2022361756B2/en active Active
- 2022-10-06 EP EP22878053.2A patent/EP4412592A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liang et al. | Endosomal escape pathways for non-viral nucleic acid delivery systems | |
| AU2015210397B2 (en) | Peptide-based in vivo sirna delivery system | |
| EP2480672B1 (fr) | Nouveaux polynucleotides et polypeptides chimeriques permettant la secretion d'un polypeptide d'interet en association avec des exosomes et leurs utilisations | |
| JP2023512833A (ja) | 新型コロナウイルス感染症に対するｍＲＮＡワクチンの組成物及び方法 | |
| CN120035678A (zh) | 用于调节循环因子的组合物和方法 | |
| JP2011525190A5 (https=) | ||
| EA028860B1 (ru) | Улучшенная липидная композиция | |
| EP3775187A1 (en) | Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome | |
| US20110293727A1 (en) | Chimeric therapeutics, compositions, and methods for using same | |
| US9017695B2 (en) | Chimeric therapeutics, compositions, and methods for using same | |
| WO2010042749A2 (en) | Chimeric therapeutics, compositions, and methods for using same | |
| CN116018405A (zh) | Trem组合物及其相关方法 | |
| JP2022502347A (ja) | 細胞透過性ペプチド | |
| WO2010042751A2 (en) | Chimeric therapeutics, compositions, and methods for using same | |
| US11834517B2 (en) | Branched peptides for enzymatic assembly and mitochondria drug delivery | |
| AU2022361756B2 (en) | Lipid nanoparticle comprising a nucleic acid-binding protein | |
| WO2021123300A1 (en) | Treatment of hepatic and cardiovascular disorders | |
| JPWO2023057935A5 (https=) | ||
| KR101715228B1 (ko) | 뎅기 바이러스 특이적 siRNA, 그러한 siRNA 를 포함하는 이중나선 올리고 RNA 구조체 및 이를 포함하는 뎅기 바이러스 증식 억제용 조성물 | |
| WO2010042742A2 (en) | Chimeric therapeutics, compositions, and methods for using same | |
| Higashi et al. | Novel lipidated sorbitol-based molecular transporters for non-viral gene delivery | |
| WO2010042743A2 (en) | Chimeric multiplexes, compositions, and methods for using same | |
| JP7716101B2 (ja) | 細胞内送達ペプチド | |
| WO2011123945A1 (en) | Compostions, methods and uses for treating respiratory syncytial virus infection | |
| JP7068711B2 (ja) | 細胞質送達ペプチド |